Etoricoxib Impurity 12 | CAS 646459-41-8 - Request Quote
Etoricoxib Impurity 12
| SZ CAT No: | SZ-E030017 |
| CAS No | 646459-41-8 |
| Mol.F. | C21H16ClN3O2S |
| Mol.Wt. | 409.9 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Etoricoxib Impurity 12 is chemically 6-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)-1,8-naphthyridine. Etoricoxib Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Etoricoxib Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Etoricoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 646459-41-8
Purchase 646459-41-8
Order 646459-41-8
Enquire 646459-41-8
price of 646459-41-8
646459-41-8 Supplier
646459-41-8 Manufacturer
646459-41-8 Exporter
buy high quality Etoricoxib Impurity 12
Purchase Etoricoxib Impurity 12
Etoricoxib Impurity 12 suppliers
Etoricoxib Impurity 12 manufacturers
Etoricoxib Impurity 12 price
Order Etoricoxib Impurity 12
Enquire Etoricoxib Impurity 12
Etoricoxib Impurity 12 cost
Etoricoxib Impurity 12 Supplier
Etoricoxib Impurity 12 Distributor
Etoricoxib Impurity 12 for Method Validation
Etoricoxib Reference Standard
Etoricoxib Impurity 12 for ANDA Filing
Etoricoxib Impurity 12 for Forced Degradation Studies
Etoricoxib Impurity 12 Identification Standards
Etoricoxib Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.